OSE Pharma SA Cash Flow Quality Index
OSE Pharma SA cash flow quality index. OSE Pharma SA (OSE) has a Cash Flow Quality Index of 1.17x as of June 2024. Operating cash flow of €66.63 Million exceeds net income of €57.17 Million, indicating high earnings quality where cash backs reported profits. See OSE free cash flow debt coverage to measure the company's free cash flow as a share of total liabilities.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Cash Flow Quality Index of OSE Pharma SA (2016–2024)
Cash flow quality index of OSE Pharma SA from 2016 to 2024. Historical Cash Flow Quality Index for OSE Pharma SA across 3 annual periods. Values consistently above 1.0x indicate high-quality earnings. Explore OSE Pharma SA cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.
OSE Pharma SA Cash Flow Quality Index by Year (2016–2024)
OSE Pharma SA cash flow quality index by year from 2016 to 2024. Year-by-year earnings quality comparison for OSE Pharma SA. For the full cash flow conversion analysis, see cash flow conversion of OSE Pharma SA.
| Year | Quality Index | Operating CF (EUR) | Net Income | YoY Change |
|---|---|---|---|---|
| 2024 | 1.29x | €48.44 Million | €37.45 Million | ▲ +559.4% |
| 2018 | 0.20x | €1.08 Million | €5.49 Million | ▲ +492.7% |
| 2016 | 0.03x | €684.00K | €20.67 Million | — |